Research output per year
Research output per year
Personal profile
Fingerprint
Dive into the research topics where Elizabeth Rakoczy is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Characterization of RNA editing and gene therapy with a compact CRISPR-Cas13 in the retina
Kumar, S., Hsiao, Y. W., Wong, V. H. Y., Aubin, D., Wang, J. H., Lisowski, L., Rakoczy, E. P., Li, F., Alarcon-Martinez, L., Gonzalez-Cordero, A., Bui, B. V. & Liu, G. S., 30 Oct 2024, (E-pub ahead of print) In: Proceedings of the National Academy of Sciences of the United States of America. 121, 45, 11 p., e2408345121.Research output: Contribution to journal › Article › peer-review
Open Access8 Citations (Web of Science) -
The promise of long-term treatment for neovascular age-related macular degeneration
Rakoczy, E. P., 20 Apr 2024, In: The Lancet. 403, 10436, p. 1517-1519 3 p.Research output: Contribution to journal › Comment/debate › peer-review
3 Citations (Scopus) -
Comparing and Contrasting the Effects of the SGLT Inhibitors Canagliflozin and Empagliflozin on the Progression of Retinopathy
Herat, L. Y., Matthews, J. R., Rakoczy, E. P., Schlaich, M. P. & Matthews, V. B., Apr 2023, In: Frontiers in Bioscience - Landmark. 28, 4, 83.Research output: Contribution to journal › Article › peer-review
Open Access9 Citations (Scopus) -
SGLT1/2 inhibition improves glycemic control and multi-organ protection in type 1 diabetes
Herat, L. Y., Matthews, J. R., Hibbs, M., Rakoczy, E. P., Schlaich, M. P. & Matthews, V. B., 18 Aug 2023, In: Iscience. 26, 8, 107260.Research output: Contribution to journal › Article › peer-review
Open Access8 Citations (Web of Science) -
Determining the Role of SGLT2 Inhibition with Dapagliflozin in the Development of Diabetic Retinopathy
Herat, L. Y., Matthews, J. R., Ong, W. E., Rakoczy, E. P., Schlaich, M. P. & Matthews, V. B., 12 Dec 2022, In: Frontiers in bioscience (Landmark edition). 27, 12, 16 p., 321.Research output: Contribution to journal › Article › peer-review
Open Access17 Citations (Scopus)
-
Dual Inhibition of SGLT1 and 2 with Sotagliflozin– a Novel Approach to Maximize Cardiorenal Protection in Type 1 Diabetes.
Herat, L. (Investigator 01), Matthews, V. (Investigator 02), Schlaich, M. (Investigator 03), Sebastian, O. (Investigator 04), Rakoczy, E. (Investigator 05) & Matthews, J. (Investigator 06)
Diabetes Research Foundation of WA
1/01/23 → 31/07/24
Project: Research
-
Investigating human vascular endothelial growth factor physiology
Mellough, C. (Investigator 01), Rakoczy, E. (Investigator 02) & Constable, I. (Investigator 03)
Ophthalmic Research Institute of Australia
1/01/21 → 31/12/21
Project: Research
-
Determining a novel role for sodium glucose co-transporter 2 in the pathogenesis of diabetic retinopathy.
Herat, L. (Investigator 01), Matthews, V. (Investigator 02), Schlaich, M. (Investigator 03) & Rakoczy, E. (Investigator 04)
Diabetes Research Foundation of WA
1/01/20 → 31/12/20
Project: Research
-
Determining a novel role for sodium glucose co-transporter 2 indiabetic retinopathy
Matthews, V. (Investigator 01), Herat, L. (Investigator 02), Schlaich, M. (Investigator 03) & Rakoczy, E. (Investigator 04)
1/01/20 → 30/06/21
Project: Research
-
Long-Term Human Response Following Subretinal Injection of Recombinant Adenoassociated Virus-sFlt-1 Vector
Rakoczy, E. (Investigator 01), Lai, C.-M. (Investigator 02), Constable, I. (Investigator 03) & Wikstrom, M. (Investigator 04)
NHMRC National Health and Medical Research Council
1/01/11 → 31/12/13
Project: Research
Prizes
-
A novel role for sodium glucose co-transporter 2 in diabetic retinopathy and nephropathy
Herat, L. (Recipient), Matthews, V. (Recipient), Schlaich, M. (Recipient) & Rakoczy, E. (Recipient), 2020
Prize: Other distinction
-